Drug eye drops recalled for manufacturing practice deviations nationwide
Dr. Berne's Organic Castor Oil Eye Drops are being recalled due to manufacturing practice deviations. The voluntary recall affects 1,744 bottles distributed nationally and internationally.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II drug recall for manufacturing practice deviations on a product applied directly to the eye, constituting a risk-of-harm product. No illnesses or injuries have been reported. Per the rubric, a High (3) severity reflects risk-of-harm products where injury has not yet been reported.
Plain-English summary
Dr. Berne's Organic Castor Oil Eye Drops, a 30 mL product distributed by Dr. Berne's Whole Health Products in Tesuque, New Mexico, have been voluntarily recalled due to Current Good Manufacturing Practice (CGMP) deviations. The FDA classified this as a Class II recall. A total of 1,744 bottles (Lot 6666, expiration 11/30/25) are affected.
The recalled product was distributed nationwide and to over 30 countries worldwide, including the United Kingdom, Canada, Australia, Germany, Switzerland, Singapore, Netherlands, Ireland, South Korea, Belgium, Norway, Saudi Arabia, Slovenia, Malta, Israel, Sweden, Latvia, Portugal, Hong Kong, Kuwait, Romania, South Africa, Thailand, Zambia, France, Finland, Mauritius, and Barbados. The firm initiated the recall on August 26, 2023, and the FDA center made its classification on October 4, 2023.
The recalled product
- Product
- Dr. Berne's Organic Castor Oil Eye Drops, Net WT 30 mL/1 fl oz bottle, Distributed by: Dr. Berne's Whole Health Products, Tesuque, NM, 87574, [email protected], Certified Organic by Organic Certifiers.
- Manufacturer
- Dr. Berne's Whole Health Products
- Category
- Drug — Ophthalmic
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 6666
- Exp. 11/30/25
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27